K183088: ADVIA Centaur Erythropoietin (EPO) assay (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K183088 (ADVIA Centaur Erythropoietin (EPO) assay, cleared 2019-08-02 for Axis-Shield Diagnostics Limited) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K183088 |
| Cleared Device Trade / Generic Name | ADVIA Centaur Erythropoietin (EPO) assay |
| FDA Applicant on Filing | Axis-Shield Diagnostics Limited |
| FDA 3-Letter Product Classification | Product Code GGT |
| FDA Substantial Equivalence Decision Date | 2019-08-02 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Inspect consolidated manufacturer lineage at Axis-Shield Diagnostics Limited, compare peer devices under FDA Product Code GGT, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.